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We report a fatal case of rickettsiosis in a woman from
the United States living in Kenya, who had a history of tick
exposure. Immunohistochemical staining of skin, kidney,
and liver demonstrated spotted fever group rickettsiae. The
clinical findings, severity, and fatal outcome are most con-
sistent with Rickettsia conorii infection. 
R
ickettsia are gram-negative, obligate intracellular bac-
teria that are able to invade various eukaryotic host
cells such as reticuloendothelial cells and vascular
endothelial cells in vertebrates, and epithelial cells in their
invertebrate arthropod vectors. Rickettsiae are transmitted
to humans through infected arthropods, and hard ticks
serve as both vectors and reservoir hosts for most spotted
fever group (SFG) rickettsiae (1).
Two SFG rickettsiae are most commonly identified in
Africa, Rickettsia conorii and R. africae. R. conorii, the
etiologic agent of Kenyan tick typhus or more commonly
known as Mediterranean spotted fever, is transmitted pre-
dominately through the bite of infected Rhipicephalus
ticks; it has been reported in Central and South Africa (2).
R. africae, the causative agent of African tick bite fever, is
transmitted by Amblyomma ticks and has also been report-
ed in South and Central Africa, including Kenya (3,4). R.
africae has also been identified in 119 travelers who had
recently visited South Africa, Swaziland, Lesotho,
Gambia, Tanzania, Kenya, Gabon, and Côte d’ Ivoire (5).
Athird SFG rickettsia, R. aeschlimannii, has recently been
described in South Africa (6).
We describe a fatal case of spotted fever rickettsiosis in
a missionary from the United States who lived in a rural
town in the central district of Kenya, approximately 70 km
north of Nairobi. Although the patient received prompt
medical attention at a private hospital, her illness was ini-
tially diagnosed as malaria, and this misdiagnosis possibly
contributed to the fatal outcome. This case emphasizes the
need to consider spotted fever rickettsioses in the diagno-
sis of patients with fever in Africa, and the importance of
determining the distribution and prevalence of these dis-
eases in this region.
Case Report
During February 1999, a 39-year-old woman sought
treatment at a hospital in Kijabe, Kenya, for a “boil” on her
lower left leg. Over the next 3 days, headache, myalgia,
chills, sweats, and a temperature of 38.5°C developed. The
patient was a missionary from the United States, who fre-
quently hiked in the forest around Kijabe with her dog.
Four days before discovering the lesion on her leg, she had
taken her ill dog to the local veterinarian. The dog, which
was frequently infested with ticks, was diagnosed with
“tick-borne fever” (an unspecified illness in dogs, associ-
ated with tick infestation) and was treated with imizol
(imidocarb dipropionate). The dog’s symptoms resolved
within 3 days. 
Five days after the onset of her symptoms, the patient
returned to the hospital when her condition had not
improved. Hematologic evaluation showed a marginal
decrease in leukocytes to 4,200/mm3 (80% polymorphonu-
clear cells, 2% bands, 17% lymphocytes, and 1%
eosinophils), and thrombocytopenia (107,000/mm3). No
malaria parasites were detected on thick or thin blood
smears. The patient was treated with acetaminophen and
released from the hospital. 
The next day, the patient returned to the hospital after
the onset of vomiting and a nonpuritic, blotchy, macular
rash on her arms and abdomen. Because she had traveled
recently to a malaria-endemic area, malaria was diag-
nosed. Treatment was initiated with three tablets of
Fansidar (500 mg sulfadoxine and 25 mg pyrimethamine
per tablet). The patient reported some improvement of
symptoms that evening, and by the following day, she
ceased vomiting and her fever was reduced. 
On the day 9 of her illness, a generalized macular rash
covered her full body, sparing her palms and soles. Her
pharynx was red. Her abdomen was tender in both upper
quadrants. A viral exanthem as well as malaria responding
to treatment were diagnosed. Vomiting and fever began
again that afternoon. That evening she became mildly con-
fused and was admitted to Kijabe African Inland Church
Mission Hospital. Her temperature was 38°C; she was
tachypnic and had a nonproductive cough. She had mild
epigastric tenderness, but spleen and liver margins were
not palpable. An eschar surrounded by a 1.5 cm purpuric
border was identified on her lower left leg. Fansidar-resist-
ant malaria as well as a viral exanthem were diagnosed,
and she was treated with intravenous fluids, quinine, acet-
aminophen, and promethazine. The following day, her
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bal commands. Multiple seizures developed, and she went
into cardiopulmonary arrest. Despite attempts at cardiopul-
monary resuscitation, the patient died. 
Histopathologic findings included extensive epidermal
and dermal necrosis and acute inflammation at the site of
the eschar with focal, transmural, mixed inflammatory cell
infiltrates involving dermal blood vessels (Figure 1). The
liver showed portal triaditis and focal eyrthophagocytosis
by Kupffer cells. The spleen showed multiple microscopic
necrotic foci involving red and white pulp. Multifocal lym-
phohistiocytic infiltrates were identified in the interstitium
of the heart and kidneys. The lungs showed mild pul-
monary edema and congestion. 
Formalin-fixed, paraffin-embedded tissue and serum
specimens were sent to the Centers for Disease Control
and Prevention for evaluation. Immunohistochemical
(IHC) staining for SFG Rickettsia demonstrated rickettsiae
and rickettsial antigens in sections of heart, spleen, and
kidney localized within and around vascular endothelial
cells and reticuloendothelial cells, predominantly in areas
associated with perivascular mononuclear inflammatory
infiltrates (Figure 2). 
Asingle serum sample, collected on the ninth day of ill-
ness, demonstrated neither immunoglobulin (Ig) G nor IgM
antibodies reactive with R. conorii when tested by an indi-
rect immunofluorescence antibody assay at a screening
dilution of 1:16. To further define the causative agent, we
attempted to amplify a portion of the rickettsial rOmpA
gene, as we have done for ticks from this region (4), using
DNA extracted from the paraffin-embedded sections of
heart, spleen, and kidneys. Briefly, paraffin-embedded tis-
sue samples were deparaffinized in xylene, and rinsed in
absolute ethanol. Genomic DNAwas extracted by using the
Wizard genomic DNA purification kit (Promega, Madison,
WI), according to the manufacturer’s protocol.
Amplification of a 635-bp fragment of the rompA gene
encoding the SFG-specific 190-kDa protein was attempted
by using primers Rr190.70p (7) and Rr190.701 (8).
Genomic DNAisolated from R. montanensis–infected Vero
cells, and water served as positive and negative controls,
respectively, for the polymerase chain reaction (PCR).
Conclusions
Immunostaining demonstrated an SFG rickettsial infec-
tion as the cause of the patient’s death; yet, because the
IHC assay reacts with several species of SFG rickettsiae
(9), a specific etiologic agent was not determined.
Serologic evaluation of a serum specimen obtained late in
the course of this patient’s illness failed to demonstrate
antibody reactive with SFG rickettsiae; however, some
patients with fatal rickettsial infections die before notable
levels of these antibodies are detected (9). 
Additionally, repeated attempts to amplify rickettsial
DNAfrom numerous thin-section preparations from paraf-
fin-embedded tissues were unsuccessful. Therefore, we
were unable to characterize the infecting rickettsiae using
molecular techniques. Sample fixation procedures may
decrease the sensitivity of the PCR, as seen in diagnostic
assays for other microorganisms (10). Further work is
needed to determine the utility of PCR as a reliable method
of detecting rickettsial DNA in paraffin-embedded tissues. 
The spectrum of rickettsial infections in Africa ranges
from mild to severe. R. conorii causes a moderate to severe
illness with a case-fatality rate of approximately 3%.
Disease is most often characterized by a single eschar and
a generalized maculopapular rash that may involve the
palms and the soles (11). By contrast, R. africae causes a
generally milder, self-limiting disease with fever, multiple
eschars, regional lymphadenopathy, and rash in approxi-
mately 16% to 46% of patients (3,12). 
Anecdotal reports and some animal and human studies
suggest that sulfa-containing antimicrobial agents exacer-
bate the clinical severity of rickettsial infections (13,14),
and the patient described here received a sulfa-containing
antibiotic after malaria was diagnosed. However, an early
correct diagnosis and prompt administration of effective
antirickettsial therapy (e.g., doxycycline or another terta-
cycline) remain the primary determinants of successful
clinical outcomes for patients with spotted fever rick-
ettsioses. Evidence is accumulating that tick-borne rick-
ettsioses are an underreported and underappreciated cause
of illness in sub-Saharan Africa. For example, while inves-
tigating this case we discovered that a mild febrile illness,
accompanied by rash, developed in nearly one third of a
group of boarding school students from the United States,
who had camped at Masai Mara, a popular tourist destina-
tion; all had histories of tick bite (J. Rutherford, unpub.
data). Additionally, recent identification of SFG rickettsiae
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Figure 1. Vasculitis and edema involving medium-sized artery in
the subcutaneous fat at the site of the eschar (hematoxylin and
eosin stain; original magnification x100).
Spotted Fever in Kenyain ticks from this area confirmed the presence of R. africae
in  Amblyomma variegatum collected from domesticated
livestock (4). Rickettsial infections in Central and sub-
Saharan Africa have been reported among tourists and
travelers who visited game reserves (12). The prevalence
of spotted fever in local populations may be obscured by
the lack of obvious rash and the overwhelming number of
cases of malaria.
This case report highlights both an immediate and a
long-term need for rickettsial surveillance and dissemina-
tion of information about rickettsioses to health care work-
ers in Africa. In a similar manner, physicians in
industrialized countries who care for ill travelers who have
visited Africa should consider rickettsial infections among
the differential diagnoses of febrile disease, particularly in
clinical situations in which malaria has been reasonably
excluded as a cause of the patient’s illness. In these con-
texts, further studies of the epidemiology and ecology of
African SFG rickettsiae and rickettsioses are warranted.
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